NifedipineLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1918卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20843-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：386 / 386

相关论文

共 50 条

[21] RituximabLack of efficacy in off-label use: case report
[J]. Reactions Weekly, 2023, 1946 (1) : 492 - 492
[22] OsimertinibLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1949 (1) : 349 - 349
[23] AzithromycinLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1878 (1) : 110 - 110
[24] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 84 - 84
[25] HydroxychloroquineLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1925 (1) : 264 - 264
[26] Multiple drugsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1931 (1) : 406 - 406
[27] Multiple drugsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1948 (1) : 300 - 300
[28] Anakinra/tofacitiniblack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1933 (1) : 42 - 42
[29] Multiple drugsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1862 (1) : 327 - 327
[30] Dexamethasone/remdesivirLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1904 (1) : 187 - 187

← 1 2 3 4 5 →